Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists (Q37842595)

24 August 2017

1 reference

title

Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists (English)

1 reference

24 August 2017

0 references

0 references

Wolfgang Müller

1 reference

24 August 2017

Matthias F. Seidel

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21323622

24 November 2024

language of work or name

English

0 references

publication date

17 February 2011

1 reference

full work available at URL

24 August 2017

http://www.informapharmascience.com/doi/abs/10.1517/14656566.2011.557362

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21323622

http://www.tandfonline.com/doi/pdf/10.1517/14656566.2011.557362

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Expert Opinion on Pharmacotherapy

24 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

1381-1391

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Fibromyalgia: a rheumatologic diagnosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The classification of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Cell death during development of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Nerve growth factor in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The effects of 5HT3 receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Role of 5-HT3 receptors in the mechanisms of central pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The influence of depression on the effect of Tropisetron in the therapy of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The relationship between fibromyalgia and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with antidepressants: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A double-blind placebo controlled trial of fluoxetine in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pregabalin: a review of its use in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Open antero-lateral dislocation of the elbow. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Pharmacological treatment of fibromyalgia syndrome: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Operant behavioral treatment of fibromyalgia: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Chronic pain may change the structure of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

Difference in pain relief after trigger point injections in myofascial pain patients with and without fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The influence of the 5‐HT3receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.557362

The assessment of vegetative and functional symptoms in fibromyalgia patients: the tropisetron experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

2660

Ray SR

2000

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Cold-induced vasospasm in patients with fibromyalgia and chronic low back pain in comparison to healthy subjects

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Evidence of augmented central pain processing in idiopathic chronic low back pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Das Fibromyalgiesyndrom — eine somatoforme (Schmerz)störung?

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Histological and neurophysiological changes induced by carrageenan in skeletal muscle of cat and rat

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Neurobiological concepts of fibromyalgia--the possible role of descending spinal tracts

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Results of the intravenous administration of tropisetron in fibromyalgia patients

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice.

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

Fortschritte der Medizin

120

Stratz T

2002

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

148

Salemi S

2003

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions.

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

[Subgroups of fibromyalgia]

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

983

Oen K

2005

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Tender points, depressive and functional symptoms: comparison between fibromyalgia and major depression

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

1975

Gendreau RM

2005

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Are antidepressants effective in fibromyalgia?

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Bulletin on the rheumatic diseases

24 November 2024

Goldenberg DL

2004

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

A randomized, controlled, trial of controlled release paroxetine in fibromyalgia

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Annals of the Rheumatic Diseases

24 November 2024

Arnold LM

2007

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

Annals of the Rheumatic Diseases

24 November 2024

Crofford LJ

2007

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

24 November 2024

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

The frequency of transition of chronic low back pain to fibromyalgia

24 November 2024

series ordinal

104

1 reference

https://api.crossref.org/works/10.1517/14656566.2011.557362

24 November 2024

Identifiers

1 reference

24 August 2017

1 reference